About The Webinar

While COVID-19 is projected to decrease global trade volumes by 13 to 30 percent this year, trade flows for personal protective equipment have grown exponentially to address urgent needs. This webinar will discuss regulatory discretion as well as restrictions that U.S. Customs and Border Protection and its partner government agencies have been exercising and considering on PPE imports in light of the crisis. 

Key Topics

  • delayed duty and revenue collection or payment
  • bond insufficiencies and collateral
  • refunds for MFN duties and section 232/301 tariff exclusions
  • response times for CBP and PGA inquiries, notices, and protests
  • CBP late payment and other enforcement claims
  • PPE emergency use authorizations and enforcement policies
  • medical device listing and registration exceptions
  • export of FEMA scarce or threatened PPE
  • PGA documentation presentation
  • cargo diversion, transit, and filing timeframes
  • inspections and requests for redelivery
  • CBP,  PGA, and other information resources

Please note we do not accept payment via American Express.


Domenic J. Veneziano

Independent FDA Regulatory and Strategic Consultant

Lenny P. Feldman


Lenny Feldman concentrates his practice in complex issues pertaining to import and export compliance, penalty mitigation, supply chain security (including CTPAT), intellectual property, and other programs. He is recognized as a leading authority on CTPAT, served on the CTPAT MSC working group of CBP’s Commercial Customs Operations Advisory Committee, and has counseled hundreds of companies through the certification, validation, and revalidation processes.



Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.